214 related articles for article (PubMed ID: 8982743)
21. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
22. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Mascarenhas L; van Beek A; Bennink HC; Newton J
Hum Reprod; 1998 Nov; 13(11):3057-60. PubMed ID: 9853856
[TBL] [Abstract][Full Text] [Related]
23. Progesterone receptor in Norplant endometrium.
Lau TM; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
[TBL] [Abstract][Full Text] [Related]
24. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
[TBL] [Abstract][Full Text] [Related]
25. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
26. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Hickey M; Fraser IS
Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
[TBL] [Abstract][Full Text] [Related]
27. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
28. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
29. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
Nilsson O; Englund D; Weiner E; Victor A
Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
31. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
Subakir SB; Setiadi E; Affandi B; Pringgoutomo S; Freisleben HJ
Toxicology; 2000 Aug; 148(2-3):173-8. PubMed ID: 10962136
[TBL] [Abstract][Full Text] [Related]
32. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
Pakarinen PI; Lähteenmäki P; Lehtonen E; Reima I
Hum Reprod; 1998 Jul; 13(7):1846-53. PubMed ID: 9740437
[TBL] [Abstract][Full Text] [Related]
33. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels.
Hourihan HM; Sheppard BL; Bonnar J
Contraception; 1986 Dec; 34(6):603-12. PubMed ID: 3103980
[TBL] [Abstract][Full Text] [Related]
34. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
35. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
Rogers PA; Au CL; Affandi B
Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
[TBL] [Abstract][Full Text] [Related]
36. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
[TBL] [Abstract][Full Text] [Related]
37. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding.
Rogers PA; Lederman F; Plunkett D; Affandi B
Hum Reprod; 2000 Aug; 15 Suppl 3():152-61. PubMed ID: 11041231
[TBL] [Abstract][Full Text] [Related]
39. NORPLANT contraceptive implants advancing.
Segal SJ
Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
[TBL] [Abstract][Full Text] [Related]
40. Immediate postpartum insertion of the norplant contraceptive device.
Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
